Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)

Abroad (travel likely)RecruitingPHASE1

Conditions

Pharmacokinetics · Healthy Volunteer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Quotient Sciences, Miami, Florida, United States
Contact: Study coordinator (Claire Swann) · Claire.Swann@quotientsciences.com
Contact: Principal Investigator (Jeffrey Levy, MD, PhD)

Study leads

Jeffrey Levy, MD, PhD
Principal Investigator
Medical Director, Quotient Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety of Increasing Doses of DF5112 in Healthy Adults

Healthy Participants · Healthy Adult Females · Healthy Adult Male

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia

A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

Healthy Volunteers

Abroad (travel likely)RecruitingPHASE1

Grayslake, United States